Here's Why This Doc Got a Third Vaccine Dose A transplant surgeon, a heart recipient himself, saw robust antibody response after third dose May 20, 2021
Probiotics Protect Overweight, Older Patients From Coughs and Wheeze Trial affirms "gut-lung" link but with important caveats May 14, 2021
Diversity in Pancreatic Cancer Trials Lacking White patients typically overrepresented at expense of racial, ethnic minorities May 14, 2021
Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment Endoscopic procedure could yield benefits now seen only with more invasive surgery May 14, 2021
Pandemic Drinking Took Swift Toll on the Gut, Liver Alcohol-related inpatient consults soared, remained high even after reopening May 14, 2021
Impressive Results With Lenvatinib in Challenging Tumors Multitargeted TKI achieves strong ORR in advanced gastroenteropancreatic NETs May 10, 2021
Op-Ed: Why the COVID Vaccine Didn't Work for Me Millions of transplant patients need to be informed that they may not get sufficient protection May 10, 2021
Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
Results Disappoint for Fecal Transplant in Arthritis But interest persists in targeting the gut-joint axis in psoriatic arthritis May 04, 2021
'It's a Straw-Man Argument': What We Heard This Week Quotable quotes from 51³ÉÈ˶¯Âþ's sources May 02, 2021
FDA Panel Splits on Anti-PD-1 Monotherapy in HCC All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
New Option for Eosinophilic Esophagitis? Special budesonide formulation topped placebo across a range of outcomes Apr 21, 2021
Can an Agile Endoscopic Device Curb PPI-Dependent GERD? GERDx device improved quality of life; not so much for esophageal acid exposure Apr 16, 2021
Perianal Involvement in Crohn’s Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
Another FGFR Inhibitor Active in Bile Duct Cancers Clinical benefit rate of 82% in patients selected for FGFR2 fusions, rearrangements Apr 13, 2021
Can a COX-2 Inhibitor Boost Disease-free Survival in CRC? Large trial tested addition of the agent to standard FOLFOX Apr 06, 2021
Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
Ethics Consult: Boozy Athlete's Liver Transplant Ethical? MD/JD Weighs In You voted, now see the results and an expert's discussion Mar 26, 2021
Minimizing the Pesky Placebo Response in IBS Trials Identifying the determinants is key to better trial design Mar 26, 2021
Op-Ed: Primary Care and Specialty Ping Pong Let's put an end to bureaucratic medicine and treat the patient in front of us Mar 21, 2021
No Help From Extra Hydration to Prevent Post-ERCP Pancreatitis Trial may settle whether aggressive, laborious procedure is justified Mar 18, 2021
Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
New Guideline Lowers Age to Begin Colorectal Cancer Screening Update comes as incidence has doubled in people under 50 Mar 09, 2021
New Targeted Therapies Show Promise in Cancer Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
Antibiotic Duo Wins in Diverticulitis Outpatient Tx Less risk for harms without adversely affecting outcomes, cohort studies show Feb 22, 2021
Anti-CD20 Drugs Tied to Severe COVID in Cancer Patients Plus: Active chemo treatment may not be a COVID risk factor Feb 05, 2021
AGA Updates Guidelines for Refractory H. Pylori New info stresses knowing patients' antibiotic exposure and doing drug susceptibility testing Feb 01, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
For Seniors with IBD, Think Safety With Treatments Hospitalizations risks were lower with vedolizumab than TNF inhibitors Jan 24, 2021
Diets Ease Symptoms in Crohn's Both the Mediterranean and Specific Carbohydrate diets were helpful in mild to moderate disease Jan 24, 2021
Low-Dose IL-2 Shows Promise in Colitis Safety and response seen in dose-ranging ulcerative colitis trial Jan 23, 2021
Aspirin and CRC Risk: A Curious Age Connection Implications for prophylactic recommendations, researchers say Jan 21, 2021
Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemo News, features, and commentary about cancer-related issues Jan 21, 2021
Preop RT Flunks Test in Borderline Pancreatic Cancer Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
